---
$id: https://graph.org.ai/products/commodity/51151671
$type: Product
source: UNSPSC
code: "51151671"
title: "Vamicamide"
class: "51151600"
classTitle: "Cholinergic blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Vamicamide

**UNSPSC Code**: 51151671
**Class**: [Cholinergic blocking agents](Cholinergic blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antimuscarinic agent with the molecular formula C18H23N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RU10K34QRU, chemically known as 2-pyridineacetamide, alpha-(2-(dimethylamino)propyl)-alpha-phenyl-, (r*,r*)-(+-)- but generally known as vamicamide, which bears US NIH Compound Identifier 65967. European Medicines Agency schedules Vamicamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00020MIG. The term VAMICAMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, No. 3 1991, List 31). VAMICAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule vamicamide under HS 29333999 and SITC 51574. As of Q4 2014, VAMICAMIDE remains the US FDA Preferred Term for this commodity. Vamicamide bears US NLM identifiers UMLS ID C0247801 and NCI Concept Code C75289. SMILES: O=C(N)C(CC(N(C)C)C)(C1CCCCC1)C1NCCCC1.

